Prior authorization, step therapy and shifting coverage rules keep patients from obesity drugs with proven benefits, an endocrinologist argues — and the long-term savings make the case for broader access.
|Articles|November 9, 2022
Coronavirus Omicron variant, vaccine, and case numbers in the United States: Nov. 9, 2022
Author(s)Logan Lutton
How many novel coronavirus (COVID-19) cases were announced today?
Advertisement
The
Here’s the latest data, updated on Nov. 9:
Positive tests: 97,797,561
Patient deaths: 1,072,921
Total vaccine doses distributed: 928,460,585
Patients who’ve received the first dose: 266,401,911
Patients who’ve received the second dose: 227,377,753
% of population fully vaccinated (both doses, not including boosters): 68.5%
% tied to Omicron variant: 100%
% tied to Other: 0%
Advertisement
Related to this article
Six questions primary care physicians should ask about indoor air quality in their practices.
Milbank Memorial Fund finds uneven training standards, workforce tracking for nurse practitioners.
Excited for the sunset of MIPS? Brace yourself for a replacement, not a repair. Here are four steps to prepare for it.
A pre-election candidate survey lands two weeks before CMS sets the next round of rural health awards, which partly score states on nurse practitioner rules.
National Association of ACOs hosts leader at fall conference.
KFF's pre-election poll found voters trust Democrats over Republicans on health care costs by 20 points, and public support for a single government plan moves sharply depending on the argument people hear.
A new University of Michigan poll finds most older adults barely review their coverage at open enrollment, and the fallout lands in the exam room and the billing office.
Advertisement
Advertisement
Trending on Medical Economics
1
ACOs are 'the best way to deliver health care,' CMS chief Dr. Oz says
2
NPs are registering new practices at nearly 6 times the 2019 rate
3
As Medicare’s new ACO model begins, kidney care cannot be left behind
4
Veterans with essential tremor can now get a nondrug wearable device through the VA
5